A detailed history of United Capital Financial Advisers, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 267,709 shares of JNJ stock, worth $41.6 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
267,709
Previous 304,597 12.11%
Holding current value
$41.6 Million
Previous $48.2 Million 18.79%
% of portfolio
0.34%
Previous 0.4%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $5.33 Million - $5.82 Million
-36,888 Reduced 12.11%
267,709 $39.1 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $2.42 Million - $2.54 Million
-15,613 Reduced 4.88%
304,597 $48.2 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $27.5 Million - $30 Million
-188,629 Reduced 37.07%
320,210 $50.2 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $4.37 Million - $4.9 Million
-28,059 Reduced 5.23%
508,839 $79.3 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $3.01 Million - $3.24 Million
-19,522 Reduced 3.51%
536,898 $88.9 Million
Q1 2023

Aug 14, 2023

BUY
$151.05 - $180.26 $1.85 Million - $2.21 Million
12,266 Added 2.28%
549,164 $85.1 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $8.87 Million - $10.6 Million
-58,733 Reduced 9.55%
556,420 $86.2 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $1.34 Million - $1.51 Million
-8,390 Reduced 1.35%
615,153 $109 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $3.87 Million - $4.3 Million
-23,970 Reduced 3.7%
623,543 $102 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $2.31 Million - $2.56 Million
13,739 Added 2.17%
647,513 $115 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $614,215 - $697,527
-3,884 Reduced 0.61%
633,774 $112 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $729,596 - $809,513
-4,679 Reduced 0.73%
637,658 $109 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $1.6 Million - $1.78 Million
9,900 Added 1.57%
642,337 $104 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $20,413 - $21,896
-128 Reduced 0.02%
632,437 $104 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $2.91 Million - $3.24 Million
19,020 Added 3.1%
632,565 $104 Million
Q4 2020

Feb 17, 2021

SELL
$137.11 - $157.38 $83,362 - $95,687
-608 Reduced 0.1%
613,545 $96.6 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $2.16 Million - $2.37 Million
15,421 Added 2.58%
614,153 $91.4 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $3.27 Million - $3.95 Million
25,425 Added 4.43%
598,732 $84.2 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $5.16 Million - $7.15 Million
-46,462 Reduced 7.5%
573,307 $68.3 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $5.95 Million - $6.84 Million
46,698 Added 8.15%
619,769 $90.4 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $5.35 Million - $5.99 Million
-42,161 Reduced 6.85%
573,071 $74.1 Million
Q2 2019

Aug 13, 2019

BUY
$131.15 - $144.24 $5.78 Million - $6.36 Million
44,064 Added 7.71%
615,232 $85.7 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $1.86 Million - $2.07 Million
14,781 Added 2.66%
571,168 $79.8 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $1.85 Million - $2.23 Million
15,058 Added 2.78%
556,387 $70.8 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $2.4 Million - $2.82 Million
19,756 Added 3.79%
541,329 $74.8 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $815,621 - $900,052
-6,831 Reduced 1.29%
521,573 $63.3 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $2.7 Million - $3.19 Million
21,566 Added 4.26%
528,404 $67.7 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $1.77 Million - $1.93 Million
13,470 Added 2.73%
506,838 $71.2 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $1.92 Million - $2 Million
14,805 Added 3.09%
493,368 $64.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
478,563
478,563 $63.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.